Domestic indices saw profit taking after rising for four consecutive trading sessions on Tuesday. The Nifty 50 index ended near the 14,850 level. Metal, private banks corrected while media and PSU banks shares advanced.
As per the provisional closing data, the barometer index, the S&P BSE Sensex, declined 340.6 points or 0.69% to 49,161.36. The Nifty 50 index fell 91.60 points or 0.61% at 14,850.10.
The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.6% while the S&P BSE Small-Cap index added 0.8%.
Buyers outpaced sellers. On the BSE, 1,845 shares rose and 1,198 shares fell. A total of 196 shares were unchanged.
Investors locked profits after the Sensex rose 2.59% and the Nifty climbed 3.08% in the past four sessions.
COVID-19 Update:
Total COVID-19 confirmed cases worldwide stood at 15,89,57,229 with 33,03,877 deaths. India reported 37,15,221 active cases of COVID-19 infection and 2,49,992 deaths while 1,90,27,304 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.
The country reported 3,29,942 cases in the last 24 hours taking the total caseload of COVID-19 cases to 2,29,92,517. The last time India recorded around 3.20 lakh cases in a day was on 27 April 2021 when a 24-hour count stood at 3,23,144 cases.
The media reported that WHO has reclassified the highly contagious triple-mutant COVID-19 variant spreading in India as a "variant of concern", indicating that it's become a global health threat. WHO official said, "We classify it as a variant of concern at a global level.
Results Today:
Godrej Consumer (up 0.64%), Kalpataru Power (down 0.84%), KEC International (up 0.39%), BASF (up 1.52%) and Alembic (down 0.15%) will announce their March quarter results.
Earnings Impact:
HSIL was locked in an upper circuit of 20% after the company's net profit surged to Rs 33.02 crore in Q4 FY21 as against Rs 3.38 crore in Q4 FY20. Net sales during the quarter increased 37.3% year-on-year (Y-o-Y) to Rs 633.21 crore. The company delivered EBITDA of Rs 102 crore, registering a robust growth of 65.5% on Y-o-Y basis. EBITDA margins improved to 15.9% in Q4 FY21 compared with 13.1% in Q4 FY20.
Paushak tumbled 4%. The company reported 72.8% jump in net profit to Rs 11.01 crore in Q4 FY21 as against Rs 6.37 crore in Q4 FY20. Net sales increased 32.3% to Rs 38.74 crore in the fourth quarter compared with the corresponding period last year. Profit before tax in Q4 FY21 stood at Rs 16.11 crore, up by 96.9% from Rs 8.18 crore in Q4 FY20.
Intellect Design Arena tumbled 7.86%. The company reported 96.7% jump in consolidated net profit to Rs 80.61 crore in Q4 FY21 as against Rs 40.99 crore in Q4 FY20.
Net sales rose 11% to Rs 397.57 crore in Q4 FY21 over Q4 FY20. Profit before tax in the fourth quarter stood at Rs 90.15 crore, up 112.9% from Rs 42.35 crore reported in the same period last year.
JMC Projects (India) slipped 1.07%. The company reported a consolidated net profit of Rs 41.44 crore in Q4 FY21 as against net loss of Rs 54.76 crore in Q4 FY20. Net sales during the quarter increased 42.6% year-on-year (Y-o-Y) to Rs 1,392.22 crore. The company posted a pre-tax profit of Rs 61.57 crore in the fourth quarter compared with pre-tax loss of Rs 52.32 crore reported in the same period last year.
HFCL soared 7.8% after the company's consolidated net profit surged to Rs 84.67 crore in Q4 FY21 from Rs 5.78 crore in Q4 FY20. Net sales during the quarter increased 109.8% to Rs 1391.40 crore from Rs 663.19 crore reported in the same period last year. On the segmental front, revenue from Telecom Products was Rs 387.82 crore (up 114.4% YoY) while that from Turnkey Contracts and Services was Rs 1,003.58 crore (up 108.1% YoY) in the fourth quarter.
Stocks in Spotlight:
Punjab National Bank was down 0.84%. The board of directors of the state-run bank approved opening of qualified institutional placement (QIP) on Monday. The board approved the floor price of Rs 35.51 per equity share for the QIP. The Capital Raising Committee of the bank will meet on Friday, 14 May, to consider and determine the issue price for the equity shares to be allotted to eligible qualified institutional buyers.
Solara Active Pharma Sciences advanced 3.17% after Shivanand Shankar Mankekar bought 8.70 lakh equity shares or 2.42% stake at Rs 1,552.05 per share of the company via bulk deal on NSE on Monday (10 May 2021). Pronomz Ventures sold 8.70 lakh equity shares of Solara Active Pharma at Rs 1,552.05 per share via bulk deal on NSE on Monday. Professor Shivanand Shankar Manekar is a high net investor (HNI) and a former a full-time professor at Mumbai's Jamnalal Bajaj Institute of Management Studies.
Federal-Mogul Goetze (India) advanced 1.87%. The firm has shut down its plant situated at Bangalore (Karnataka) starting from 10 May till 15 May 2021 in view of the current pandemic situation in the region.
UPL rose 1.36%. The company has announced that its subsidiary has entered into a license agreement with Japanese company, Meiji Seika Pharma Co., for exclusive access to Flupyrimin for rice in Southeast Asia. Under the license agreement, UPL will obtain exclusive rights to develop, register and commercialize formulations of Flupyrimin for foliar applications in rice in Southeast Asia, expanding the on-going collaboration between the two companies with this compound.
Global Markets:
Shares in Europe and Asia declined on Tuesday, following a sell-off in tech stocks that weighed down major U. S. indexes overnight.
In the US, technology shares led the broader market lower on Monday as investors dumped high-flying Big Tech stocks, pushing the Dow Jones Industrial Average and the S&P 500 off their record highs.
Investors around the world are also focused on the latest inflation data this week. US inflation data will release on Wednesday amid growing concerns that the Federal Reserve will be prompted to tighten its monetary policy stance as prices rise along with the reopening of the global economy.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU